PRICE T ROWE ASSOCIATES INC /MD/
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,238,289
-$8,889,286 QoQ
Shares Held
207,047
-67.4% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ACAD ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,238,289 | 207,047 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,127,575 | 634,662 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,431,163 | 615,169 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,492,842 | 1,100,883 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,033,158 | 928,751 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,786,184 | 649,379 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,395,533 | 621,010 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,150,245 | 659,964 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,951,397 | 920,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $73,951,679 | 3,999,550 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $162,139,116 | 5,178,509 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $108,996,554 | 5,230,161 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $144,033,239 | 6,013,914 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $85,648,050 | 4,550,906 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $68,125,723 | 4,279,254 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $80,022,453 | 4,891,348 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $66,134,444 | 4,693,715 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $120,589,829 | 4,978,936 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $221,409,331 | 9,486,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $156,674,555 | 9,432,544 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $248,749,488 | 10,198,831 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $215,533,483 | 8,354,011 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $421,148,524 | 7,877,825 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $434,656,942 | 10,537,138 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $549,736,367 | 11,341,786 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $499,728,986 | 11,827,905 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||